In this context, aryl hydrocarbon receptor (AhR) signaling pathways are thought to be involved in regulating skin homeostasis in response to environmental exposure, which may have therapeutic implications for the pharmacologic management of AD [37,38]. The gene discussed is AHR; the disease is Alzheimer disease.